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Abstract
Understanding how neural cells handle proteostasis stress in the endoplasmic reticulum (ER) is important to decipher the
mechanisms that underlie the cell death associated with neurodegenerative diseases and to design appropriate therapeutic
tools. Here we have compared the sensitivity of a human neuroblastoma cell line (SH-SY5H) to the ER stress caused by an
inhibitor of protein glycosylation with that observed in human embryonic kidney (HEK-293T) cells. In response to stress, SH-
SY5H cells increase the expression of mRNA encoding downstream effectors of ER stress sensors and transcription factors
related to the unfolded protein response (the spliced X-box binding protein 1, CCAAT-enhancer-binding protein
homologous protein, endoplasmic reticulum-localized DnaJ homologue 4 and asparagine synthetase). Tunicamycin-
induced death of SH-SY5H cells was prevented by terminal aromatic substituted butyric or valeric acids, in association with a
decrease in the mRNA expression of stress-related factors, and in the accumulation of the ATF4 protein. Interestingly, this
decrease in ATF4 protein occurs without modifying the phosphorylation of the translation initiation factor eIF2a. Together,
these results show that when short chain phenyl acyl acids alleviate ER stress in SH-SY5H cells their survival is enhanced.
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Introduction
The administration of 4-phenylbutyrate (PBA) is indicated as
adjunct therapy in the chronic management of patients with
disorders of the urea cycle that involve deficiencies of either
carbamoylphosphate synthetase, ornithine transcarbamoylase or
argininosuccinate synthetase [1,2]. Phenylacetate produced by
PBA metabolism may be conjugated to glutamine to form
phenylacetylglutamine, which serves as an alternative to urea in
ammonia excretion. Furthermore, PBA is potentially beneficial in
the treatment of sickle cell disease, thalassemia, cancer, cystic
fibrosis, spinal muscular atrophy, amyotrophic lateral sclerosis and
type 2 diabetes mellitus [3–11]. In these pathologies, PBA appears
to enhance both gene transcription and protein synthesis due to its
properties as an histone deacetylase (HDAC) inhibitor [12].
Protein misfolding and aggregation are known to be associated
with pathologies like Alzheimer’s, Parkinson’s or Huntington’s
diseases [13]. Interestingly, PBA produces beneficial effects in
animal models of these neurodegenerative diseases, both by
inhibiting HDACs and by acting as a chemical chaperone that
reduces the stress in the endoplasmic reticulum (ER) caused by
huntingtin, alpha-synuclein, p-tau or beta-amyloid (see [12] for
review). It was recently shown that PBA protects against ER stress-
induced neuronal cell death [14], an effect that was correlated with
a marked increase in H3 histone acetylation and a decrease in the
expression of glucose-regulated protein 94 (GRP94), whose
transcription augments in response to defects in N-linked
glycosylation [15].
N-linked glycosylation is a key step early in the folding of most
proteins that takes place within the endoplasmic reticulum.
Tunicamycin is a drug that inhibits this process and that provokes
the accumulation of misfolded proteins in the ER, the main
hallmark of ER stress. In turn, ER stress triggers a compensatory
mechanism, the unfolded protein response (UPR), and the three
independent transmembrane ER stress sensors activated by ER
stress – IRE1, PERK and ATF6– initiate three independent
signaling mechanisms that converge on an integrated program of
gene expression aimed to provide relief (Fig. 1). The most
conserved step in UPR signaling is the non-conventional splicing
of XBP1 mRNA that is initiated by IRE1, a transmembrane ER
resident protein that contains a kinase and endonuclease domain
in its cytosolic region. Upon activation, the Ire1 RNAse domain
can excise a 26 nucleotide intron from within the mRNA coding
for the XBP-1 transcription factor. Translation of this alternatively
spliced XBP1 mRNA produces a very active transcription factor
that drives the transcription of a vast set of UPR genes. IRE1/
XBP1 splicing is the most highly conserved signaling component
of the UPR and it is critical to determine the fate of cells in
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response to ER stress [16,17]. However, the role of this splicing
event in neurodegeneration still remains controversial.
Several other genes are known to be involved in the UPR. For
example, following its synthesis activating transcription factor 6
(ATF6) is anchored to the surface of the endoplasmic reticulum
through a C-terminal transmembrane domain. ER-localized
ATF6 is inactive, although ER deficiencies drive the translocation
of this protein to the Golgi apparatus, where it is processed by site1
and site2 proteases [18]. This processing releases the functional
ATF6c transcription factor which then travels to the nucleus to
activate the transcription of chaperone genes [19]. The multido-
main transmembrane protein PERK also contains an ER stress
sensor and a kinase domain in its cytosolic region. ER stress causes
the clustering of PERK in the plane of the endoplasmic reticulum
and the activation of its kinase domain, which phosphorylates the
translation initiation factor eIF2a and dampens protein synthesis.
PERK-dependent inhibition of cellular translation alleviates the
protein load in the ER as the phosphorylation of eIF2a impairs the
translation of most mRNAs. However, a small subset of messenger
RNAs containing small upstream open reading frames (uORFs)
benefit from eIF2a phosphorylation and they are preferentially
translated under these conditions. The ATF4 transcription factor
is one such protein and it activates a subset of transcripts that
either enhance the folding capacity of the ER or promote
apoptosis [20].
Here, we examine the activation of UPR signaling in response
to tunicamycin in the SH-SY5H cell line, and the cell death caused
by this insult. Based on this characterization, we examined the
capacity of two phenyl acids, PBA and 5-phenylvalerate (PVA), to




Tunicamycin (Sigma-Aldrich, MO, USA) was prepared in PBS
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM
KH2PO4) as a 10 mM stock solution with 5% (v/v) DMSO at
pH 7.4.
4-Phenyl butyric acid (PBA) and 5-Phenyl valeric acid (PVA)
were purchased from Sigma (Sigma-Aldrich, MO, USA), and
10 mM solutions were prepared by titrating equimolecular
amounts of PBA or PVA with sodium hydroxide to pH 7.4.
Cell Culture
The SH-SY5Y cell line was obtained from ATCC (CRL-2266)
[21] and cultured in 35 mm (for RNA isolation) or 60 mm (for
protein isolation) plates (Becton Dickinson, NJ, USA). The cells
were grown to 90% confluence at 37uC in an atmosphere of 5%
CO2 and in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with Glutamax (Gibco, Invitrogen, CA, USA),
100 units/ml penicillin/streptomycin, 16 MEM non-essential
amino acids and 10% fetal bovine serum (FBS).
The HEK-293T cell line was obtained from ATCC (CRL-1573)
[22] and the cells were grown in DMEM supplemented with
Figure 1. Scheme showing the three major ER-stress sensors: PERK, ATF6 and IRE1 and the link to the targets assayed in this report.
Activated PERK phosphorylates eIF2a to attenuate protein translation but allowing the expression of ATF4-dependent genes, CHOP and ASNS,
involved in redox- and apoptosis-related pathways. Cleaved -active- ATF6 leads to induction of molecular chaperones (GPR78) and of the
transcription factor XBP1. IRE1 activation leads to XBP1 splicing, transcriptional activation of chaperones and stimulation of protein degradation
through ErdJ4, which is a component of the ER-associated degradation (ERAD) system.
doi:10.1371/journal.pone.0071082.g001
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2 mM L-glutamine, 1 mM sodium pyruvate, 100 units/ml pen-
icillin/streptomycin, 16MEM non-essential amino acids and 5%
(v/v) FBS. All the media and supplements were purchased from
Invitrogen, (CA, USA).
Cell death assay
To establish the optimal concentration of tunicamycin that
produces a measurable amount of SH-SY5Y cell death, the cells
were treated with different concentrations of this drug for 48 h and
cell death was monitored by quantifying lactate dehydrogenase
(LDH) release into the cell media with the Cytotoxicity Detection
Kit (Roche Diagnostics IN, USA). The analysis was carried out
according to the manufacturer’s recommendations and the
absorbance was measured at 450 nm with a microplate reader.
To assess the effects of PBA or PVA on survival, SH-SY5Y cells
were exposed to these compounds for 24 h at the concentrations
indicated and they were then treated with 500 nM tunicamycin
for 48 h.
Quantitative Real-Time PCR
Total RNA was extracted from SH-SY5Y or HEK-293T cells
using a method based on that of Chomczynski and Sachi’s [23]
and the TRI reagent (Sigma-Aldrich, MO, USA). Briefly, cells
were washed with PBS and lysed with 1 ml Trizol reagent, and
after a 5 min incubation at room temperature, the lysate was
mixed vigorously with 0.2 ml of chloroform. The sample was then
centrifuged at 12,000 g for 15 min at 4uC, and the supernatant
was recovered and placed in a fresh tube containing 0.5 mL
isopropanol. After incubating for 10 min at room temperature, the
RNA pellet was obtained by centrifugation at 12,000 g for 10 min
at 4uC. The pellet was washed in 1 mL ethanol (75%) and once all
the ethanol had been removed, it was dissolved in 30 ml diethyl
pyrocarbonate (DEPC)-treated water.
2 mg of total RNA obtained was used as a template to synthesize
cDNAs with the SuperScriptH III First-Strand Synthesis System
for RT-PCR (Invitrogen, Life technologies). Real-time quantita-
tive PCR assays were then performed in triplicate on these cDNAs
in the presence of the PCR Master Mix (Power SYBRHGreen,
Applied Biosystems, Warrington, UK) to detect the amplification
products. Samples were analyzed simultaneously for ribosomal
protein 36B4 mRNA as an internal control using an ABI Prism
7300 sequence detector (Applied Biosystems, Foster City, CA,
USA), and the data were analyzed using Sequence Detection
software v. 3.0. (Applied Biosystems). The primer sequences for
quantitative PCR are indicated in Table 1.
Protein extracts
Total protein homogenates were obtained by homogenizing the
cells in ice-cold lysis buffer (200 mM NaCl, 5 mM EDTA,
100 mM HEPES pH 7.4, 10% glycerol, 2 mM Na4P2O7, 1 mM
EGTA, 2 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride and
the CompleteTM Protease inhibitor cocktail [Roche Diagnostics,
Mannheim, Germany]) that contained phosphatase inhibitors
(1 mM Na3VO4, 200 mM NaF). The homogenates were disrupt-
ed by passing them through a 27G needle and they were then left
on ice for 30 min before they were centrifuged at 11,000 g for
20 min at 4uC. The protein concentration was determined using
the Bradford assay (Bradford protein assay, Bio-Rad, CA, USA)
and aliquots were stored at 280uC.
Immunoblotting
Protein samples were mixed with 66 Laemmli sample buffer
resolved on 10% SDS-polyacrylamide gels and transferred to
nitrocellulose membranes. The membranes were blocked with 5%
milk in Tris-buffered saline (TBS –50 mM Tris, 150 mM NaCl
pH 7.4) containing 0.05% Tween-20 and then probed overnight
with primary rabbit polyclonal antisera against: rabbit polyclonal
phospho eIF2a (1:1000 Cell Signaling Technology, Beverly, MA),
Figure 2. Tunicamycin-induced ER stress in SH-SY5Y cells. A)
SH-SY5Y cells were treated for 48 h with the indicated concentrations of
tunicamycin and cell viability was determined using a LDH release
assay. Bars represent the percentage of LDH release over that obtained
in untreated cells: *p,0.05; ***p,0.0001 vs untreated cells. B–C) The
transcriptional activity of different sensors was used to monitor the
induction of ER stress by tunicamycin in SHSY-5Y (B) and HEK-293T (C)
cells. Bars represent the fold change (mean 6 SEM) in gene expression
normalized to the control untreated cells: *p,0.05; **p,0.005; vs
control untreated cells.
doi:10.1371/journal.pone.0071082.g002
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rabbit polyclonal anti-ATF4(1:1000 Santa Cruz Biotechnology CA,
USA), rabbit polyclonal anti caspase 3 (1:300 Cell Signaling
Technology, Beverly, MA) and mouse polyclonal anti-actin
(1:2000 Sigma-Aldrich, MO, USA). Following two washes in
TBS/Tween20 and one in TBS alone, the immunolabeled proteins
were detected with a HRP-conjugated anti-rabbit or anti-mouse
antibody (1:5,000 Santa Cruz Biotechnology), which was visualized
by enhanced chemiluminiscence (ECL, GE Healthcare Bioscience,
Buckinghamshire,UK) and autoradiography using HyperfilmT-
MECL (GE Healthcare Bioscience). Quantity OneTM software
v.4.6.3 (Bio-Rad) was used for quantification.
Data analysis and statistical procedures
The results are reported as the means 6 SEM and they were
analyzed with the SPSS package for Windows, version 15.0 (SPSS,
Chicago, IL,USA). All measurements were taken in triplicate from
three independent experiments. The Shapiro Wilks test was used
to evaluate the fit of the data to a normal distribution and the
Levene test to evaluate the homogeneity of variance. Significance
was tested using one-way ANOVA followed by a Tukey’s multiple
range test.
Results
The effect of the ER stress inducer, tunicamycin, on cell death
measured by the LDH activity released to the culture medium was
assayed in human neuroblastoma SH-SY5H cells. We observed a
dose-dependent increase in cell death that reached a plateau at
concentrations of 0.5 and 1 mM tunicamycin (Fig. 2A). Higher
concentrations of tunicamycin (10 or 100 mM) caused massive cell
death in the cultures. Accordingly, the tunicamycin concentration
selected to measure the activation of components of the UPR and
the neuroprotection afforded by the phenyl acyl acid compounds
was 500 nM. When the expression of selected UPR mediators was
measured by RT-PCR, exposure to tunicamycin increased the
mRNA expression of all of them: spliced XBP-1 and spliced XBP-
1/total ratio, CHOP, endoplasmic reticulum-localized DnaJ
homologue 4 (ERdJ4) and asparagine synthetase (ASNS). More-
over, the cytotoxic effect of tunicamycin was rapid as it was
stronger at 10 h than at 24 h (Fig. 2B). A similar experiment was
performed with HEK-293T cells, in which UPR activation has
been documented previously, yet the enhanced expression of these
UPR substrates induced by tunicamycin (500 nM) was not as
pronounced as in neuroblastoma cells (Fig. 2C). These results
suggest that neuroblastoma cells are more sensitive to tunicamycin
than other cells for which concentrations up to 0.125 mM have
been used to measure stress-related effects [24].
Significant protection against the cell death provoked by a
submaximal 10 h and 24 h exposure to tunicamycin was offered
by PBA or PVA (see Methods). LDH measurements indicated that
both PBA and PVA offered dose-dependent protection against
neuroblastoma cell death that reached a plateau at low mM levels
in both cases (Fig. 3A–B). The levels of proapoptotic active caspase
3 were also determned and the results indicated both that
tunicamycin increased the levels of the cleaved form of the enzyme
and that PBA or PVA reverted them to the values obtained with
media alone (Fig. 3C). The treatment of cells with PBA or PVA
(1 mM) significantly impaired the tunicamycin-induced upregula-
tion of the ER stress marker, BiP, also known as the glucose-
regulated protein 78 (GPR78: Fig. 4A). As indicated earlier, stress-
mediated IRE-1 activation (such as that produced by tunicamycin)
leads to the specific splicing of the mRNA encoding XBP-1 [25], a
modification that was significantly diminished by both PBA and
PVA (Fig. 4B). Indeed, after 10 h in the presence of tunicamycin,
PBA or PVA-treated cells displayed a two-fold decrease in the
levels of spliced XBP1 mRNA, a reduction that was even more
pronounced after 24 h of treatment (Fig. 4B). The protein
translated from the spliced XBP-1 mRNA, Xbp1s, controls the
expression of the ER co-chaperone ERdj4, which is upregulated
by ER stress. Indeed, this protein has been implicated in ER-
associated degradation (ERAD) of multiple unfolded secretory
proteins. When the effect of PBA and PVA on ErdJ4 mRNA
expression was analyzed, the increase in expression provoked by a
10 h treatment with tunicamycin (Fig. 2B) was not modified by
either compound. However, while PVA provoked a significant
decrease in expression at 24 h, the effect of PBA was not
significant (Fig. 4C).
PERK signaling is also activated under conditions of ER stress
and it augments the expression of the activating transcription
factor 4 (ATF4), which is in turn dependent on the phosphory-
lation status of the translation initiation factor eIF2a. Enhanced
phosphorylation of eIF2a triggered by 10 h tunicamycin treatment
Figure 3. PBA and PVA protect SH-SY5Y cells against tunicamycin induced ER stress. SH-SY5Y cells were exposed to tunicamycin (500 nm)
for 24 h in the absence (medium) or in the presence of PBA (panel A) or PVA (panel B). Cell viability was determined using a LDH release assay and the
results are expressed as the means 6 SEM. Bars represent the percentage of LDH release over that obtained in untreated cells. **p,0.005;
***p,0.0001 vs tunicamycin treated cells (Medium). Panel C. Immunoblot of procaspase 3 and cleaved caspase 3. A representative image is shown
and the bar diagram represents the ratio of cleaved versus total protein (mean 6 SEM) in the different conditions and normalizad to the ratio in
absence of tunicamycin. ##p,0.005 vs untreated cells; **p,0.005 vs tunicamycin treated cells.
doi:10.1371/journal.pone.0071082.g003
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was not further increased by either PBA or PVA (Fig. 5A).
However, expression of eIF2a was similar to that of control after
24 h of treatment with tunicamycin (with or without PBA or
PVA). In contrast, PBA or PVA were able to revert the significant
increase of ATF4 expression by 10 h-treatment with tunicamycin
(Fig. 5B). This PBA or PVA effect was not observed at the later
time (Fig. 5B). Although PERK-dependent eIF2a phosphorylation
is known to shutdown translation, mRNAs containing upstream
open reading frames (uORFs) can bypass this block, as occurs with
ATF4, which in turn activates ASNS transcription. A similar effect
occurs with the pro-apoptotic protein CHOP, which is also
transcriptionally activated by ATF4. Significantly, PBA and PVA
decreased the expression of CHOP at both time points when
measured by RT-PCR (Fig. 6A), and ASNS expression was also
significantly diminished, except when cells were exposed to
tunicamycin for 24 h following treatment with PBA (Fig. 6B).
Together, these results indicate that PBA and PVA do not affect
PERK signaling at the level of eIF2a phosphorylation but rather,
after 10 h of tunicamycin-induced stress they significantly decrease
ATF4 expression, leading to the downregulation of ASNS and
CHOP expression. Moreover, PVA drives this effect more
markedly than PBA.
Discussion
The results presented here suggest that modulation of the ER
stress responses may offer protection against neural cell death,
such as that provoked by both PBA and PVA. As a chemical
chaperone, PBA is a well-known modulator of proteostasis, and in
vitro, PVA has also been shown to act as a chemical chaperone
[14]. PBA and PVA may in part modulate the tunicamycin-
induced stress response by diminishing the amount of unfolded
proteins due to their intrinsic chemical chaperone activity.
However, the modulation of stress-related gene expression, which
was similar for PBA and PVA, may also be caused by other
overlapping mechanisms. It was shown that in an early-onset
model of Alzheimer’s disease, the severity of the amyloid
Figure 4. PBA and PVA neutralize the ER stress sensors induced
by tunicamycin. SH-SY5Y cells were treated as described in the
Materials and Methods and the expression of GPR78 (A), spliced XBP1
(B) and ERdJ4 (C) was determined by RT-PCR. The bars represent the
expression (mean 6 SEM) normalized to that of the corresponding
36b4 internal control: *p,0.05; **p,0.005 vs tunicamycin treated cells.
doi:10.1371/journal.pone.0071082.g004
Figure 5. Western blots of SHSY-5Y cells treated with PBA or
PVA probed with anti-phospho eIF2a (A) and anti-ATF4 (B). The
bars represent the ratio of eIF2a or anti-ATF4 versus b-actin expression
and referred to the ratio in tunicamycin-treated cells (mean 6 SEM).
*p,0.05, vs tunicamycin treated cells.#p,0.05 vs untreated cells.
doi:10.1371/journal.pone.0071082.g005
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pathology is related to the pronounced dysregulation of histone
acetylation in the forebrain, and that recovery of memory function
was correlated with elevated hippocampal histone acetylation and
enhanced expression of genes implicated in associative learning
[26]. When either sodium butyrate or PBA are used, the
cognition-enhancing effects and the regulation of histone deace-
tylation may be related [27–32]. Whereas sodium butyrate and
PBA positively influence the transcriptional regulation of cogni-
tion-related genes, as reported here, PBA may also negatively
regulate gene transcription [33]. In fact, PBA and PVA appear to
be more closely associated with a decrease in the expression of
factors upregulated in response to stress. Under the specific cell
culture conditions used here, SH-SY5H cells invoke a complex
transcriptional response to tunicamycin that involves the three
UPR signaling branches. It is particularly notable that 10 h after
such stress is triggered a large amount of mRNA for spliced XBP-1
and for CHOP accumulates. Interestingly, both PBA and PVA
negatively modulate stress-related transcription, and while this
response was qualitatively and quantitatively similar for both
aromatic acyl acids, the downregulation provoked by PVA on
ERdJ4 and ASNS transcription was more sustained than that of
PBA. Nevertheless, this difference in UPR modulation dynamics
does not seem to be important for neuroprotection, as both offered
similar levels of neuroprotection. Together these results show a
correlation between the neuroprotection afforded at 24 h with the
negative regulation of stress-gene transcription that peaked at
10 h.
Under similar experimental conditions the stress response
elicited in neuroblastoma cells was stronger than in HEK-293T
cells, which may explain why studies using non-neuronal cells are
performed with higher concentrations of tunicamycin. In highly
tunicamycin-sensitive SH-SY5H cells, the decrease in the mRNA
transcripts from stress genes was correlated with stronger
neuroprotection, suggesting that in this neural cell model the
negative modulation of ER stress/ER stress signaling 10 h after
stress is triggered benefits survival. In fact, at this time both PBA
and PVA significantly reduced the expression of GPR78, spliced
Xbp-1, ERdJ4, CHOP and ASNS mRNAs. Furthermore, while
the decrease in ERdJ4 expression would expected as a conse-
quence of downregulating XBP-1 splicing, the weaker expression
of CHOP and ASNS was correlated with the loss of the ATF4
protein. Interestingly, the downregulation of PERK signaling was
not correlated with decreased phosphorylation of the eIF2a
translation initiation factor by PERK. This may be due to a delay
between mRNA downregulation and that of protein phosphory-
lation. In fact, an increase in eIF2a phosphorylation seems to be
required to produce the switch in the translation machinery that
promotes the synthesis of mRNA coding for PERK-specific factors
(ATF4, CHOP and ASNS) [34]. Alternatively, the activation of
CHOP or ASNS in neurons may not be entirely dependent on the
PERK pathway, although this would be in contrast with findings
in human hepatoma cells [35], in which transcriptional induction
of the ASNS gene during the unfolded protein response requires
the PERK but not the ATF6 and IRE1/XBP1 arms of the stress
pathway.
Events associated with ER-stress have been linked to the
pathogenesis of Alzheimer’s disease, which is characterized by the
accumulation of amyloid-derived products. In fact, rescue the ER-
stress-induced suppression of amyloid precursor protein has been
shown to be one of the beneficial actions of PBA, thereby
preventing apoptosis in neuroblastoma NAG cells [36]. Interest-
ingly, the intracellular domain of the amyloid precursor protein
(AICD) enhances the sensitivity of human SHEP neuroblastoma
cells to apoptosis induced by tunicamycin [37]. Therefore, it seems
that it may be beneficial to address ER-stress in pathological
conditions in which proteins accumulate in the CNS (e.g.,
Alzheimer’s or Huntington’s disease, tauopathies or synucleino-
pathies). The present report shows that both PBA and PVA
dampen the activation of genes involved in the ER stress response
caused by inhibiting N-linked protein glycosylation. Tuning down
ER stress or ER stress-derived transcription soon after ER stress
occurs may be critical to mitigate the toxic challenge. The
contribution of PBA or PVA to neuroprotection via this effect
merits attention.
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